Document is current
Any future updates will be listed below
-
Authors
Dhakal, Rohit https://orcid.org/0000-0002-7722-7065
Sanchez, Nilda C. https://orcid.org/0009-0000-0486-7179
Gawne, Timothy J. https://orcid.org/0000-0002-5634-4393
Khanal, Safal https://orcid.org/0000-0002-3755-8046
-
Funding
Funding for this research was provided by:
National Eye Institute (R01 EY028578)
National Eye Institute (R21 EY036536)
E. Matilda Ziegler Foundation for the Blind
American Academy of Optometry
Meta
- License Information
-
More Information
Article History
Received: 12 December 2025
Accepted: 23 February 2026
First Online: 30 March 2026
Declarations
:
: SK has received funding from Meta. TJG has several provisional patents for optical myopia control therapies and has received funding from ALCON and Meta. All other authors declare no competing interests.
: This study followed all applicable institutional (UAB IACUC # 22448) and/or national guidelines for the care and use of animals.
: There are no human subjects in this study.
: There are no human subjects in this study.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All experimental procedures using animal models were described and approved by the Institutional Animal Care and Use Committee at the University of Alabama at Birmingham (UAB) (Protocol #22448).
